Impact of Bone Marrow Pathology on the Clinical Management of Philadelphia Chromosome–Negative Myeloproliferative Neoplasms

Clinical Lymphoma, Myeloma and Leukemia - United States
doi 10.1016/j.clml.2014.11.002
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Determination of Prognosis of Philadelphia Chromosome-Negative Myeloproliferative Neoplasms With a Simple Clinical Examination: Retrospective Analysis of 71 Patients in a Single Institution

Molecular and Clinical Oncology
Cancer ResearchOncology
2015English

Sequential B-Lymphoid and Myeloid Blastic Transformation of Philadelphia Chromosome-Negative Myeloproliferative Neoplasm

British Journal of Haematology
Hematology
2018English

Evaluation of Thrombin Generation in Classical Philadelphianegative Myeloproliferative Neoplasms / Evaluarea Generării Trombinei În Neoplasmele Mieloproliferative Philadelphia- Negative

Revista Romana de Medicina de Laborator
2016English

Italian Survey on Clinical Practice in Myeloproliferative Neoplasms. A GIMEMA Myeloproliferative Neoplasms Working Party Initiative

American Journal of Hematology
Hematology
2019English

The Ph-Positive and Ph-Negative Myeloproliferative Neoplasms: Some Topical Pre-Clinical and Clinical Issues

Haematologica
Hematology
2011English

Myeloproliferative Neoplasms: Morphology and Clinical Practice

American Journal of Hematology
Hematology
2016English

Current Pre-Clinical and Clinical Advances in the BCR-ABL1-positive and -Negative Chronic Myeloproliferative Neoplasms

Haematologica
Hematology
2014English

Advances in Understanding and Management of Myeloproliferative Neoplasms

CA - A Cancer Journal for Clinicians
OncologyHematology
2009English

Highlights: Focus on Bone Marrow Pathology

Journal of clinical and experimental hematopathology : JCEH
Medicine
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy